Biogen named Spotlight Leadership Company
Erie, PA - Outsourced Pharma Boston will feature Biogen as its Spotlight Leadership Company at its conference for professionals of biotech, pharma, and contract development and manufacturing organizations (April 26 -27 at the Boston Park Plaza). The session is titled: Manufacturing Strategy: How Biogen Positions Outsourcing & Partnering as a Foundational Element of Its Network.
Panelists for this session include the following members of Biogen’s Pharmaceutical Operations & Technology organization: Thomas Holmes, Sr. Director for Global External Manufacturing; Clive Patience, VP, Asset Development & Program Management; Walter Charles, Chief Procurement Officer; and Patrick Soares, Sr. Director External Manufacturing. The panel will be moderated by Louis Garguilo, Chief Editor & Conference Chair, Outsourced Pharma.
The presentation will focus on how to create a comprehensive strategic framework to develop, manufacture, and deliver biopharmaceutical products that create value for patients, employees, and shareholders. Key themes in the discussion focused on outsourcing will include:
“We’re excited to be a part of this year’s Outsourced Pharma Boston conference. I enjoyed my experience as an Outsourced Pharma panelist in 2016, and now along with my colleagues at Biogen, we are happy to become the Spotlight Leadership Company this year,” said Thomas Holmes, Sr. Director for Global External Manufacturing at Biogen. “This open forum for discussion and learning between supply chain partners and drug owners is of great value to our industry."
“We are honored to have Biogen as our Spotlight Leadership Company at Outsourced Pharma Boston 2017,” said Louis Garguilo, Chief Editor and Conference Chair for Outsourced Pharma. “Over the past year, I’ve had the pleasure of working directly with Thomas Holmes, who is a member of our Outsourced Pharma Editorial Board, and would like to thank him and the other Biogen members for creating this session for our attendees. Learning from Biogen about manufacturing outsourcing strategy, criteria for selecting supply chain partners, and the role of procurement in the process, will add to the knowledge of all our companies attending our Boston forum this year."
With this event in Boston, Outsourced Pharma enters its fourth year of hosting thought leadership conferences and exhibitions that provide discussions of best practices and practical applications of outsourcing skills, with an open format for panel and audience participation. This year’s conference in Boston is titled: A Summit on Modern-Day Drug Development and Manufacturing Outsourcing. All Outsourced Pharma conferences provide opportunities for attendees to learn about specific aspects of biotechnology and pharmaceutical outsourcing, interact with a cross-section of industry members, and generate new business opportunities.
For the full agenda and speaker biographies, visit www.outsourcedpharmaevents.com.
Outsourced Pharma Conference and Exhibition Dates:
April 26-27, 2017 | Boston
August 22-23, 2017 | San Diego
October 17-18, 2017 | San Francisco
About Outsourced Pharma Conference and Exhibition
Outsourced Pharma Conference & Exhibition is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing. These conferences and exhibitions form a community for networking and discussing topics most relevant to sponsor-provider partnerships and supply-chain management, within an open format that promotes panel and attendee interaction.
OutsourcedPharma.com provides comprehensive analysis of global outsourcing, the biotechnology and pharmaceutical industries, and their intersection with the overall life sciences and healthcare markets. We offer readers a deeper exploration and understanding of the relationships between service providers and their bio and pharma sponsors.
About Life Science Connect
Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.